Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

By now, you’ve perhaps heard of looksmaxxers, the young men pursuing extreme physical transformation in the belief that appearance is the sole determinant of social and sexual success. If not, I’m ...

Oracle-based quantum algorithms cannot use deep loops because quantum states exist only as mathematical amplitudes in Hilbert space with no physical substrate. Criticall ...

BTDUex cryptocurrency exchange, a global leader in intelligent finance, today officially announced the launch of its 2026 flagship strategic initiative: a global smart trading competition with a ...

Those that solve artificially simplified problems where quantum advantage is meaningless. Those that provide no genuine quantum advantage when all costs are properly accounted for. This critique is ...

A new study reveals the dual use of a FAP molecule that inhibits fibrosis and facilitates drug delivery, offering insights ...

As the program engages more directly with global concerns such as the climate crisis, he will lead the way.

The new version of the container and VM manager extends GPU support for AMD hardware and introduces cluster recovery ...

Here's Why. Ethereum remains a focal point for institutional on-chain activity even as price momentum stalls. In 2026, Ether has retreated about 36% for the year, slipping back from the $3,000 milesto ...